Approval · Notice of Compliance 8991 · 2007
EMEND: Notice of Compliance 8991
Issued August 24, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8991
- Date
- August 24, 2007
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Neurokinin 1 receptor antagonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EMEND | 02298805 | Marketed |
| EMEND | 02298791 | Marketed |
| EMEND TRI-PACK | 02298813 | Marketed |
Medicinal ingredients
- APREPITANT 125 MG per CAP
- APREPITANT 80 MG per CAP